Related Experiment Video
Updated: Jun 30, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications
Ghader Babaei1, Samin Sadraei2, Maral Yarahmadi3
1Department of Clinical Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Insights
Cardiovascular diseases (CVD) are a major global health concern. This review explores how signal transducer and activator of transcription (STAT) pathways contribute to CVD pathogenesis and their potential as therapeutic targets.
Area of Science:
- Biomedical Science
- Molecular Biology
- Cardiology
Background:
- Cardiovascular diseases (CVD) represent a significant global health burden and a primary cause of mortality.
- Understanding the molecular mechanisms underlying CVD pathogenesis is a critical scientific objective.
- The signal transducer and activator of transcription (STAT) signaling pathway is implicated in diverse physiological and pathological processes.
Purpose of the Study:
- To elucidate the intricate relationship between STAT signaling pathways and the development of cardiovascular diseases.
- To review the current evidence highlighting the role of STAT proteins in various CVDs.
- To explore the therapeutic potential of targeting STAT signaling pathways for CVD treatment.
Main Methods:
- Literature review of studies investigating STAT signaling in cardiovascular disease.
- Analysis of molecular mechanisms linking STAT pathways to CVD pathogenesis.
- Synthesis of research findings on the relevance of STAT family proteins in different CVDs.
Main Results:
- STAT signaling pathways are demonstrably involved in the molecular mechanisms of cardiovascular diseases.
- STAT family proteins play a crucial role in the pathogenesis of various CVDs.
- Evidence supports the significant relevance of STAT proteins in numerous cardiovascular conditions.
Conclusions:
- STAT signaling pathways are integral to the development and progression of cardiovascular diseases.
- Targeting STAT signaling pathways presents a promising therapeutic strategy for managing CVD.
- Further research into STAT pathways could unlock novel treatments for cardiovascular conditions.
Abstract:
Globally, cardiovascular diseases (CVD) are one of the significant causes of death and are considered a major concern of human society. One of the most crucial objectives of scientists is to reveal the mechanisms associated with the pathogenesis of CVD, which has attracted the attention of many scientists. Accumulating evidence showed that the signal transducer and activator of transcription (STAT) signaling pathway is involved in various physiological and pathological processes. According to research on the molecular mechanisms of CVDs, the STAT family of proteins is one of the most crucial players in these diseases. Numerous studies have demonstrated the undeniable relevance of STAT family proteins in various CVDs. The aim of this review is to shed light on how STAT signaling pathways are related to CVD and the potential for using these signaling pathways as therapeutic targets.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Pathophysiology of Heart Failure
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pathophysiology of Cardiac Performance
Cardiovascular Drugs: Classification based on Therapeutic Indications

